Search Results

Tumor Grading and Cancer Staging Understanding how severe a person's cancer is and how aggressive the tumor behaves is crucial for treatment. Because there are many types of cancer and tumors, doctors use systems to give a number to show how bad the cancer is (called cancer staging) and how abnormal the cells in the tumor look (called tumor grade). These numbers help doctors predict how the cancer might progress and guide the treatment plan for each patient. A Tumor is Graded Under the Microscope Biopsy The process begins by obtaining a tumor biopsy from a patient and preparing samples either by formalin-fixation paraffin embedding (FFPE) or freezing in liquid nitrogen. The samples are then sectioned and stained, allowing the oncologist to assess the size, shape and organization of the tumor cells under a microscope. Tumor Status (T) Refers to the size/extent of main tumor. Higher the number, greater the size and spread. Graded The tumor is then graded depending on the unique histology, or cell pattern. A tumor grade typically ranges from 1 (well differentiated) to 4 (undifferentiated or anaplastic). Grade 1 tumors are well differentiated, grow slowly and are considered the least aggressive. Meanwhile, tumors with grades 3 or 4 are described as undifferentiated and the most aggressive in behavior. Nodal Status (N) Refers to the number and location of lymph nodes containing cancer. Higher the number, the more lymph nodes that contain cancer. Stage This is where cancer staging comes in. A cancer stage not only factors in the tumor grade, but also the tumor size, position, spread, number of tumors, cell type, and involvement of neighboring lymph nodes. There are four stages of cancer and are depicted in roman numerals from I to IV. Stages increase as the primary tumor grows and spreads into other parts of the body. In some cases, stage 0 may be used to describe neoplastic cells that are localized and not yet cancerous. Metastasis Status (M) Refers to the status of metastasis of the cancer to other parts of the body. TNM staging system (Tumor, Nodes and Metastasis) Tumor Status (T) Chart TX: The primary tumor cannot be evaluated. T0 (T plus zero): No evidence of a primary tumor. T1: The tumor is located only in the thymus or has grown into the nearby fatty tissues. T1a: The tumor has spread into fat surrounding the thymus or T1b: The tumor has grown into the lining of the lung next to the tumor (called mediastinal pleura). T2: The tumor has grown into the nearby fatty tissue and into the sac around the heart, called pericardium. T3: The tumor has spread to nearby tissues or organs, including the lungs, the blood vessels carrying blood into or out of the lungs, or the phrenic nerve, which controls breathing. T4: The tumor has spread to nearby tissues or organs, including the windpipe, esophagus, or the blood vessels pumping blood away from the heart. Nodal Status (N) Chart The “N” in the TNM staging system stands for lymph nodes. These tiny, bean-shaped organs help fight infection. Lymph nodes near where the cancer started are called regional lymph nodes. Lymph nodes in other parts of the body are called distant lymph nodes. NX: The regional lymph nodes cannot be evaluated. N0: The tumor has not spread into lymph nodes N1: The tumor may have spread to nearby lymph nodes. N2: The tumor has spread to lymph nodes deep in the chest cavity or neck. Metastasis Status (N) Chart Finally, the “M” in the TNM system describes whether the cancer has spread to other parts of the body, called distant metastasis. M0 (M plus zero): The disease has not metastasized. M1: The tumor has spread to other organs near the thymus, such as the lung and blood vessels. M1a: The tumor has spread to the lining of the lung, called the pleura, or lining of the heart, called the pericardium M1b: The tumor may have spread to the lining of the lung or the heart. Simplified TNM Chart *These details are for reference only and should not substitute professional diagnosis or medical advice.

Paraneoplastic Syndromes: Neurological Complications as Early Warning Signs of Cancer Section Title Paraneoplastic syndromes are rare disorders that occur when the body’s immune system reacts to a hidden cancer, attacking not only the tumor but also healthy tissues. These syndromes often result in neurological symptoms such as difficulty walking, muscle weakness, and sensory loss, and can affect nearly any part of the nervous system. What makes paraneoplastic syndromes particularly intriguing is that they often manifest before the cancer itself is detected, serving as early warning signs that something is amiss. The types of cancer most commonly associated with paraneoplastic syndromes include lung, breast, ovarian, and lymphoma. The exact mechanism is not fully understood, but it is believed that the body’s immune system mistakenly targets normal cells that share antigens with the tumor. For example, one of the most well-known paraneoplastic syndromes is Lambert-Eaton myasthenic syndrome, which causes muscle weakness and is associated with small cell lung cancer. The presence of neurological symptoms in a patient without a known cancer diagnosis often triggers a search for a hidden malignancy. Once the underlying cancer is found and treated, the symptoms of the paraneoplastic syndrome may improve or stabilize. However, in some cases, the neurological damage is permanent, even after the cancer is under control. Early detection of cancer through the recognition of paraneoplastic syndromes can be lifesaving, as these disorders often indicate that the cancer is in its early stages. This connection between neurology and oncology highlights the importance of a multidisciplinary approach in diagnosing and treating complex cancer-related conditions.

The Pervasiveness of Cancer in the Digital Era Section Title In today’s digital era, cancer has emerged as a significant public health challenge, affecting millions worldwide. The accessibility of information, the rise of social media, and advancements in technology have dramatically changed the landscape of cancer awareness, diagnosis, and treatment. While the digital age has fostered increased awareness and education about cancer, it has also highlighted its pervasive nature. Increased Awareness and Education The internet has transformed how people access information about cancer. Patients can now research their symptoms, treatment options, and connect with others who share similar experiences through online forums and social media platforms. This wealth of information empowers patients to advocate for their health and make informed decisions about their treatment. However, the downside of this digital access is the spread of misinformation. Many individuals may encounter unverified or misleading information about cancer treatments, leading to confusion and potential harm. As a result, patients must navigate a complex landscape of information to find credible sources and guidance. ​ Enhanced Screening and Early Detection Digital advancements have also improved cancer screening and early detection. Technologies such as telemedicine allow for remote consultations, making it easier for patients to receive care and follow-up. Additionally, artificial intelligence and machine learning are being utilized to analyze medical data, identify patterns, and improve diagnostic accuracy, leading to earlier intervention and better outcomes. ​ The Inefficiency of Relying Solely on Chemical Treatments Despite these advancements, traditional cancer treatments, primarily chemotherapy and radiation, often come with significant side effects and limitations. Many patients experience fatigue, nausea, and other debilitating symptoms, leading to reduced quality of life during treatment. Moreover, these chemical treatments do not guarantee success, as cancer cells can become resistant, resulting in treatment failures. ​ ECCT: A Step Toward Innovative Solutions In response to the limitations of conventional therapies, ECCT has emerged as an avant-garde approach. ECCT utilizes low-frequency electric fields to disrupt cancer cell proliferation while promoting the health of surrounding tissues. By focusing on the cancerous cells' bioelectrical properties, ECCT offers a non-invasive alternative that may enhance the efficacy of traditional treatments. ​ As we continue to navigate the complexities of cancer in the digital age, embracing innovative solutions like ECCT could pave the way for more effective and holistic cancer care. By integrating technology, patient education, and advanced treatment methods, we can improve outcomes and quality of life for those affected by cancer.

Recognizing Cancer Symptoms Section Title Blood cancer symptoms can vary based on the specific type, such as leukaemia, lymphoma, myeloma, MDS, or MPN. It's important to recognize these symptoms early, as timely diagnosis can significantly impact treatment outcomes. Common Blood Cancer Symptoms Some general symptoms to watch for include: Unexplained weight loss Bruising or bleeding without a clear cause Lumps or swellings in areas like the neck, armpits, or groin Shortness of breath Drenching night sweats Persistent, recurrent, or severe infections Unexplained fever (38°C or above) Rashes or itchy skin Bone, joint, or abdominal pain Persistent tiredness that doesn’t improve with rest Paleness (pallor) These symptoms can appear differently on various skin tones. For example: Bruises may initially be hard to see on darker skin but will eventually appear darker than the surrounding skin. Rashes might look purple or darker on darker skin tones, while appearing red or purple on lighter skin. Paleness is more noticeable in the eyelids, gums, and nail beds for those with darker skin. When to Seek Medical Advice If you notice any of these symptoms, especially if they’re unexplained or persistent, it’s crucial to consult a doctor. Ask about the possibility of blood cancer and whether you need tests such as blood tests, biopsies, or scans. Early diagnosis can lead to better treatment outcomes, so don’t hesitate to get checked out if you’re concerned.

Which Cancers Are Most Survivable and Why? Section Title Cancer survival rates can vary widely, with some cancers having significantly better outcomes than others. For instance, skin cancers such as basal and squamous cell carcinomas boast a 99.9% five-year relative survival rate. This is largely due to early detection and their common appearance on the skin, making them easier to remove surgically before they spread. Prostate and thyroid cancers also have high survival rates of 99% and 98%, respectively when detect at early stage. These cancers are often indolent, meaning they grow very slowly and may not require aggressive treatment. Additionally, both prostate and thyroid cancers often depend on hormones for growth. By targeting these hormones, treatments can effectively slow or stop cancer progression. Testicular cancer is another example, with a 95% five-year relative survival rate when detect at early stage. This cancer typically affects younger men and is often detected early, making it more treatable. Similarly, Hodgkin lymphoma has an 86% survival rate due to advances in chemotherapy and radiation therapy, especially when detected in its early stages. Melanoma, a more aggressive form of skin cancer, has a relatively high survival rate of 92%, despite its potential to spread quickly. The key factor here is early detection—since melanoma appears on the skin, it can be noticed and treated before it becomes too advanced. On the other hand, cancers like pancreatic cancer have a much lower five-year survival rate, around 7%. This is primarily due to late detection. Pancreatic cancer often does not cause symptoms until it has already spread, making it difficult to treat effectively. By the time it is diagnosed, it has usually accumulated multiple mutations, making it resistant to many therapies. There’s also an evolutionary aspect to cancer survivability. Solid tumors, like those found in the pancreas or lungs, often require a significant number of mutations before they become problematic. This diversity within the tumor makes it more challenging to treat, as resistant cells are likely to survive initial treatments. In contrast, blood cancers, like leukemia and lymphoma, typically require fewer mutations to cause disease, making them more responsive to treatment. The concept of tumor diversity has important implications for treatment strategies. For tumors with low diversity, curative therapy is more likely to be successful. However, for tumors with high diversity, managing therapeutic resistance becomes a priority. Techniques like adaptive therapy, which adjusts treatment based on the tumor’s response, may be more effective in these cases. Surgeons often play a critical role in curing cancer, particularly when the tumor is localized and can be removed before it spreads. Skin cancers, which are often detected early, are a prime example of how surgery can lead to high survival rates. In conclusion, the survival rates for different cancers are influenced by a combination of factors including early detection, the nature of the cancer, its reliance on hormones, and the diversity of mutations within the tumor. Understanding these factors can guide more effective treatment strategies and improve outcomes for patients.

Complementary Electric-Field Well-being Therapy Series Healthy immune system are both essential for overall well-being. Sleep plays a crucial role in the body's ability to repair and regenerate cells, including those of the immune system. During sleep, the body produces cytokines, proteins that help fight infection, inflammation, and abnormal development in the body. Lack of sleep can lead to a weakened immune system, making it more difficult for the body to fight and recover. ​ A healthy immune system is also critical for overall health and well-being. The immune system defends the body against harmful invaders like viruses, bacteria, and cancer cells. A weakened immune system can make it more difficult for the body to fight off infections and to stay healthy

Environment Surrounding Tumor The environment surrounding our organ cells plays a vital role in their health and functioning. When this environment is healthy, our cells operate normally. Conversely, if it's unhealthy, our cells become compromised and function abnormally. ​ Conversely, an unhealthy environment for these cells can arise when any of the above factors are not in balance or present in excess. This could include: The presence of toxins, acidic compounds, infectious agents, imbalanced acidity levels, lack of essential nutrients or oxygen, hormonal imbalances, high sugar levels, low white blood cell count, or exposure to external disturbances like radiation exposure. When the cellular environment becomes significantly unhealthy, beyond the body's ability to maintain balance (homeostasis), cells might start growing and dividing abnormally. Over time, this abnormal growth can develop into cancerous tumors. In simpler terms, a clean, safe, and balanced environment supports a healthy community, a well-maintained environment around our cells supports their proper function and overall health. ​When this environment is healthy, our organ cells thrive and function optimally. What does a healthy environment entail? ​ No harmful substances: This means no toxins, be they organic, inorganic, or heavy metals. Absence of acidic compounds from food fermentation in the gut: These acids can disturb the balance. Protection from infectious agents: Bacteria and viruses can disrupt the harmony within this environment. Maintaining balanced metabolic acidity: If acidity levels rise too high, it can negatively impact the cells. Proper supply of essential nutrients: Cells require the right amounts of necessary elements to function well. Adequate oxygen levels: Oxygen is vital for cell health and energy production. Balanced hormone levels: Hormones play a crucial role in cell communication and function. Healthy sugar levels: Too much or too little sugar can be harmful to cell health. Maintaining appropriate white blood cell levels: These cells help fight off infections and maintain a healthy environment. Avoidance of external disturbances like radiation: Disruptions from external factors, like radiation, can also impact the cellular environment. The foundational causes triggering highly unfavorable conditions in the environment around organ cells, leading to irregular cell division and the potential emergence of cancerous tumors, stem from distinct primary factors: Imbalanced Health: Resulting from an unhealthy lifestyle and diet can disrupts the balance of bacteria in the body. This allows fermentative acids from food to enter the bloodstream, negatively impacting the environment around organ cells. Heavy Metal Exposure: Heavy metals can leach these substances into the bloodstream, affecting the surroundings of organ cells and contributing to an unhealthy state. Toxic Surroundings: Exposure to a toxic home or work environment can lead to the absorption of harmful substances through the skin or lungs, entering the bloodstream and adversely affecting the environment around organ cells. Poor Nutrition: Inadequate intake of essential nutrients results in low levels of these vital elements in the bloodstream, depriving the environment surrounding organ cells of necessary nutrients, making it unhealthy. Lack of Physical Movement: Reduced muscular activity leads to sluggish blood and lymph circulation, resulting in diminished oxygenation and detoxification in the environment around organ cells, contributing to its unhealthy state. Malfunctioning Mitochondria: When mitochondria fail to produce sufficient cellular energy, it leads to increased lactic acid excretion into the environment around organ cells, making it unhealthy. Chronic Stress and Hormonal Imbalance: Prolonged stress triggers an overdrive in the sympathetic nervous system, elevating stress hormone levels and causing hormonal imbalances in the bloodstream. This imbalance affects the environment around organ cells, rendering it unhealthy. ​ Identifying and addressing these primary factors and their impact on the environment surrounding organ cells is crucial for preventing or minimizing the conditions that can lead to irregular cell division and the formation of cancerous tumors. Efforts to mitigate these factors could significantly contribute to maintaining a healthier cellular environment and reducing the risk of cancer development. Here's how electric field therapy may helps with cellular environment Electrical Balance: ECCT focuses on restoring the electrical balance within cells. If there are disturbances, such as those caused by external factors like EMF, this therapy aims to counteract or normalize these imbalances. Cellular Health: By targeting electrical properties, ECCT may aim to create an environment where cells can function optimally. This aligns with the idea that a healthy cellular environment supports healthy cell function. Potential Impact on Tumor Growth: The theory behind ECCT suggests that by restoring proper electrical balance within cells, it might influence the abnormal growth patterns seen in cancer cells.

Understanding blood parameters during chemotherapy is a crucial part of your care plan. While chemotherapy can impact various aspects of your blood and organ functions, being aware of these changes empowers you to take proactive steps towards your well-being: Hemoglobin (Hb) and Red Blood Cells (RBC): White Blood Cells (WBC): Red Blood Cells (RBC): Platelets: Liver Function: Albumin: ALT (Alanine Aminotransferase) AST (Aspartate Aminotransferase): ALP (Alkaline Phosphatase): Kidney Function: Sodium (Na) and Potassium (K): Urea and Creatinine: Calcium (Ca): Glucose: Chemotherapy might affect bone marrow function, potentially leading to decreased red blood cell production and hemoglobin levels. This awareness helps in managing anemia-related symptoms like fatigue, weakness, and shortness of breath. Chemotherapy-induced myelosuppression might lower white blood cell counts, impacting your body's ability to fight infections as the body's ability to fight off pathogens is compromised. Being informed allows you to take preventive measures to reduce infection risks. Chemotherapy-induced myelosuppression may result in a decrease in red blood cell production, contributing to anemia. Therapy can cause thrombocytopenia, reducing platelet counts and increasing the risk of bleeding, bruising, and prolonged clotting problem. Monitoring this parameter helps in timely intervention to maintain healthy blood clotting functions. Chemotherapy may influence liver function, impacting markers like albumin, globulin, ALT, AST, and ALP levels. Regular monitoring helps in detecting and managing any liver-related issues effectively. Chemotherapy may impact the liver's ability to synthesize albumin, leading to decreased levels. Low albumin levels can affect fluid balance. Chemotherapy drugs can cause hepatotoxicity, resulting in elevated levels of ALT and AST. Monitoring these markers helps assess liver function. Elevated ALP levels may indicate liver damage induced by certain chemotherapy agents. It can be a marker of cholestasis or liver cell damage. Observing sodium, potassium, urea, creatinine, calcium, and glucose levels is vital in monitoring kidney function and electrolyte balance during chemotherapy. This allows for proactive measures to maintain optimal kidney health and manage any potential imbalances. Electrolyte imbalances, including changes in sodium and potassium levels, may occur with certain chemotherapy drugs, leading to symptoms such as weakness or irregular heartbeats. Chemotherapy can affect kidney function, leading to an increase in urea and creatinine levels. Elevated levels may indicate impaired renal function. Some chemotherapy drugs, particularly those used for bone-related cancers, may impact calcium levels. Some cancers, especially those that have spread to the bones (bone metastases), can release calcium into the bloodstream as the bones are broken down. Some cancers produce substances, such as parathyroid hormone-related protein (PTHrP), which can increase calcium levels by stimulating the release of calcium from bones. Certain cancers may affect the kidneys' ability to regulate calcium levels, leading to an increase in calcium in the blood. Cancer patients may experience dehydration due to various factors, and this can contribute to elevated calcium levels in the blood. Hence, monitoring the calcium level in the blood test is essential to detect any abnormalities. Chemotherapy may influence glucose metabolism. Some drugs can lead to changes in blood glucose levels, potentially affecting patients with or without pre-existing diabetes.

Cancers by Body Location or System There are more than 200 types of cancer and we can classify cancers according to where they start in the body, such as breast cancer or lung cancer. We can also group cancer according to the type of cell they start in. AIDS-Related cancer AIDS-Related Lymphoma Primary Central Nervous System Lymphoma Kaposi Sarcoma Eye Melanoma, Intraocular Retinoblastoma Genitourinary Bladder Cancer Kidney (Renal Cell) Cancer Penile Cancer Prostate Cancer Renal Pelvis and Ureter Cancer, Transitional Cell Testicular Cancer Urethral Cancer Wilms Tumor and Other Childhood Kidney Tumors Head and Neck Hypopharyngeal Cancer Laryngeal Cancer Lip and Oral Cavity Cancer Metastatic Squamous Neck Cancer with Occult Primary Mouth Cancer Nasopharyngeal Cancer Oral Cavity Cancer, Lip and Oropharyngeal Cancer Paranasal Sinus and Nasal Cavity Cancer Parathyroid Cancer Pharyngeal Cancer Salivary Gland Cancer Throat Cancer Thyroid Cancer Skin Cutaneous T-Cell Lymphoma (see Mycosis Fungoides and the Sézary Syndrome) Kaposi Sarcoma Melanoma Merkel Cell Carcinoma Skin Cancer T-Cell Lymphoma, Cutaneous (see Mycosis Fungoides and the Sézary Syndrome) Breast Breast Cancer Breast Cancer, Childhood Breast Cancer and Pregnancy Male Breast Cancer Endocrine and Neuroendocrine Adrenocortical Carcinoma Islet Cell Tumors, Pancreatic Neuroendocrine Tumors Neuroendocrine Carcinoma of the Skin (Merkel Cell Carcinoma) Neuroendocrine Tumor, Gastrointestinal Parathyroid Cancer Paraganglioma Pheochromocytoma Pituitary Tumor Thyroid Cancer Gynecologic Cervical Cancer Endometrial Cancer Fallopian Tube Cancer Gestational Trophoblastic Tumor Ovarian Epithelial Cancer Ovarian Germ Cell Tumor Ovarian Low Malignant Potential Tumor Primary Peritoneal Cancer Uterine Sarcoma Vaginal Cancer Vulvar Cancer Neurologic Brain Tumor, Adult Brain Tumor, Childhood Astrocytomas Brain and Spinal Cord Tumors Treatment Overview Brain Stem Glioma Central Nervous System Atypical Teratoid/Rhabdoid Tumor Medulloblastoma and Other Central Nervous System Embryonal Tumors Central Nervous System Germ Cell Tumors Craniopharyngioma Ependymoma Neuroblastoma Pituitary Tumor Primary Central Nervous System (CNS) Lymphoma Musculoskeletal Bone Cancer Ewing Sarcoma Osteosarcoma and Undifferentiated Pleomorphic Sarcoma of Bone Treatment Chordoma Rhabdomyosarcoma, Childhood Soft Tissue Sarcoma Digestive / Gastrointestinal Anal Cancer Appendix Cancer (see Gastrointestinal Neuroendocrine Tumor) Bile Duct Cancer Colon Cancer Esophageal Cancer Gallbladder Cancer Gastric Cancer Gastrointestinal Stromal Tumors (GIST) Islet Cell Tumors, Pancreatic Neuroendocrine Tumors Liver Cancer, Adult Primary Liver Cancer, Childhood Neuroendocrine Tumor, Gastrointestinal Pancreatic Cancer Rectal Cancer Small Intestine Cancer Stomach (Gastric) Cancer Germ Cell Central Nervous System, Childhood Extracranial Germ Cell Tumor, Childhood Extragonadal Germ Cell Tumor Ovarian Germ Cell Tumor Testicular Cancer Hematologic/Blood Leukemia Acute Lymphoblastic Leukemia, Adult Acute Lymphoblastic Leukemia, Childhood Acute Myeloid Leukemia, Adult Acute Myeloid Leukemia, Childhood Chronic Lymphocytic Leukemia Chronic Myelogenous Leukemia Hairy Cell Leukemia Lymphoma AIDS-Related Lymphoma Cutaneous T-Cell Lymphoma (see Mycosis Fungoides and the Sézary Syndrome) Hodgkin Lymphoma, Adult Hodgkin Lymphoma, Childhood Hodgkin Lymphoma During Pregnancy Mycosis Fungoides Non-Hodgkin Lymphoma, Adult Non-Hodgkin Lymphoma, Childhood Non-Hodgkin Lymphoma During Pregnancy Primary Central Nervous System Lymphoma Sézary Syndrome T-Cell Lymphoma, Cutaneous (see Mycosis Fungoides and the Sézary Syndrome) Waldenström Macroglobulinemia (see Non-Hodgkin Lymphoma) Other Chronic Myeloproliferative Neoplasms Langerhans Cell Histiocytosis Multiple Myeloma/Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Respiratory/Thoracic Lung Cancer, Non-Small Cell Lung Cancer, Small Cell Pleuropulmonary Blastoma, Childhood Tracheobronchial Tumors, Childhood Malignant Mesothelioma Thymoma and Thymic Carcinoma

Deadliest cancers and their telltale signs! Section Title Cancer remains one of the leading causes of death worldwide, with certain types posing more significant risks based on factors such as gender and age. It’s important to learn as much as possible about the varieties of cancer and their unique risks to prepare yourself for worst-case scenarios. To be forewarned is to be forearmed. For men, the most dangerous cancers include: Lung Cancer: The leading cause of cancer death, often due to smoking and late detection. Symptoms include persistent cough, chest pain, shortness of breath, and coughing up blood. Prostate Cancer: Common but with high survival rates if detected early. Symptoms to watch for include difficulty urinating, blood in urine, and pelvic pain. Colorectal Cancer: Linked to diet, lifestyle, and family history, often deadly if untreated. Key symptoms are changes in bowel habits, rectal bleeding, and abdominal pain. For women, the most dangerous cancers are: Breast Cancer: The most common cancer in women, early detection is key to survival. Watch for lumps in the breast, changes in breast shape, or discharge from the nipple. Lung Cancer: Also prevalent due to smoking and environmental factors. Symptoms are similar to those in men. Colorectal Cancer: Similar risks as in men, with a significant mortality rate. Symptoms include changes in bowel habits, rectal bleeding, and abdominal pain. Early detection and lifestyle changes are critical for reducing the risk and improving outcomes. Regular screenings, awareness of symptoms, and avoiding risk factors like smoking and poor diet can significantly lower the danger posed by these cancers. However, it’s vital to acknowledge that even healthy people develop cancer despite eating responsibly. If you notice any symptoms, please consult a medical professional immediately. Educating yourself on the risks, maintaining a healthy lifestyle, and seeking regular medical check-ups can make a life-saving difference. Do not wait until the eleventh hour to save yourself.

Managing Lymphedema: Tips for Better Control and Quality of Life Section Title Lymphedema is a condition caused by the buildup of lymph fluid in the body's tissues, leading to swelling, typically in the arms or legs. It often occurs as a result of cancer treatments, surgery, radiation therapy, or genetic factors that damage or impair the lymphatic system. Managing lymphedema is crucial to improving quality of life and preventing complications. Here are key tips for managing the condition: ​ 1. Compression Therapy Compression garments, such as sleeves or stockings, help reduce swelling by applying pressure to the affected area. These garments encourage the movement of lymph fluid, preventing it from accumulating. For optimal results: Wear compression garments as prescribed by your doctor. Make sure they fit properly; they should not be too tight or too loose. Replace them every 6-12 months as they lose elasticity over time. 2. Manual Lymphatic Drainage (MLD) Manual lymphatic drainage is a specialized massage technique that helps stimulate the movement of lymph fluid. It should be performed by a certified therapist, but some patients are taught self-massage techniques. Regular sessions can: Decrease swelling. Improve circulation. Reduce the discomfort and pain 3. Exercise and Physical Activity Exercise plays an important role in managing lymphedema. Movement encourages the flow of lymph fluid, reducing swelling and improving flexibility. Low-impact exercises such as walking, swimming, and yoga are beneficial. Here are some guidelines: Focus on gentle, repetitive movements that engage the affected area. Start slow and gradually increase intensity with the guidance of your healthcare provider. Wear your compression garment during exercise to maximize the benefits.

ECCT Complementary cancer THERAPY A Cancer Treatment Designed with Family at Heart, Not Just Clients. Enhance cancer survival rates, regenerate health and improve quality of life. *The EXCLUSIVE and authorized distributor for ECCT in South East Asia and South Asia. Cancer Treatment Medical Team Testimonials Research Articles ECCT seamlessly blends cutting-edge science with everyday life, offering a revolutionary way to regenerate health and enhance your quality of life. ​ ECCT may be the solution if you faced below problems: ​ Tried all options but the disease is still progressing. Blood tests prevent continuing current treatments. Reduce side effects from current treatments. Maintain blood results and body functions during chemotherapy. Shrink tumors and improve quality of life. Prevent the disease from spreading. Prevent disease recurrence. Boost the immune system to fight cancer. Try safe, advanced, and innovative cancer treatments. ​ Finally, a treatment that ticks all the right boxes! Electric fields have been proven to increase survival rates. Does not harm normal cells. Near-zero side effects, and can be combined with other treatments. Can direct electric fields to any part of the body. No age limit; suitable for patients from 9 months to 90 years old. Supported by numerous survivor testimonials. Provides lifetime protection to prevent recurrence. A supportive team and specialist doctor care for lifetime. Recovery in the comfort of your home. Induced Cancer Cells Death Electric fields can trigger or programmed cell death in cancer cells. This controlled process removes damaged or unwanted cells without causing inflammation. Electric fields disrupt mitochondrial membrane potential and activate pro-apoptotic factors that start the cell death process. This targeted method selectively kills cancer cells while sparing healthy ones. Disruption of Cancer Cells Cellular Structures Electric fields significantly affect the structure of cancer cells. By altering the arrangement of cellular parts like the cytoskeleton and plasma membrane, they impair the cells' ability to maintain their shape and function. This disruption hampers crucial processes like cell division and movement, ultimately reducing the tumor's ability to grow and spread. Cancer Cells Membrane Ion Control Electric fields affect ion movement across the cell membrane, changing the cell's electrical properties. This ion transfer alters membrane potential and permeability, impacting cellular signaling and metabolism. By modifying these ion gradients, electric fields disrupt the balance within cancer cells, making them more vulnerable to treatment. Enhanced Drug Delivery to Cancer Cells Electric fields enhance the delivery and effectiveness of chemotherapy. By increasing the permeability of tumor blood vessels and cancer cell membranes, electric fields help more drugs enter the cancer cells. This improved delivery ensures higher concentrations of the drugs reach the target cells, making the treatment more effective and reducing overall side effects. Boost Immune System Electric fields can boost the immune system's response to cancer. They trigger a type of cell death that makes tumor antigens more visible to the immune system, improving its ability to recognize and destroy cancer cells. This can lead to a stronger and longer-lasting anti-tumor response, aiding in long-term remission and reducing the risk of cancer spread. Inhibition of New Blood Vessels on Cancer Cells Angiogenesis, or the creation of new blood vessels, is crucial for tumor growth and spread. Electric fields can inhibit angiogenesis by disrupting the signaling pathways that control blood vessel formation. By limiting the supply of nutrients and oxygen to the tumor, electric fields help slow down tumor growth and reduce its ability to spread. ​ Electroporation on Cancer Cells Electric fields cause electroporation, where high-intensity electric pulses make cell membranes temporarily permeable. This allows therapeutic agents like DNA, RNA, or drugs to enter cancer cells more easily. Electroporation boosts the delivery of these agents inside the cells, making treatments more effective. Cancer Cell Cycle Arrest Electric fields can stop the cell cycle, especially during division of cancer cells. By disrupting cancer cell cycle progression, electric fields prevent cancer cells from dividing and growing. This interruption slows tumor growth and boosts the effectiveness of other treatments. Cancer Cells DNA Damage and Repair Inhibition Electric fields can directly damage the DNA of cancer cells and disrupt their repair mechanisms. This dual effect causes genetic damage to accumulate, leading to cell death and reducing the chances of cancer progression. ​Multi Mechanisms Underlying Electric Field Effects in Cancer Therapy DISCLAIMER: All the information above are understood based upon independent-research and clinical observations of diagnosis & treatment administered to numerous patients by Revotera, its specialist doctor-mentors, and peers in the field of holistic therapy. These fundamental for disease & treatment represent only the the fundamental upon which the therapy protocol for ECCT are based, and not to be considered as the fundamental established by any medical governing body nor to replace any professional medical advise by any professional medical practitioners. Maximize Expertise and Efficiency: We invest in highly qualified and experienced healthcare professionals to deliver the most efficient and effective treatment. ​ Ensure Customers Pay Less : Customers pay for what truly matters; no unnecessary fees from fancy renovations or luxury branding ​ Durability Over Aesthetics : Built to last, prioritizing functionality and reliability ​ Stability Over Fancy : Focusing on simple operation and effective outcome ​ ​ Necessity Over Luxury : Prioritizing essential aspects, avoiding unnecessary luxuries Newsfeed 播放影片 播放影片 07:17 Why using Electric Field for cancer wellness? Why Do We Need Holistic Therapy? Why using Electric Field for cancer wellness? Why Do We Need Holistic Therapy? There are many cancer treatments available in the market. As patients or healthcare providers, it's crucial to consider various factors when planning cancer treatment. Our decisions will ultimately affect the outcomes, so we need to weigh all the pros and cons carefully. Always check Dr. Chandran's list of suggestions before committing to any treatment. At the end of the day, our focus should not only be on eliminating cancer cells but also on protecting and maintaining the wellness of our normal cells to ensure a good quality of life. 播放影片 播放影片 Role of an interventional radiologist What is the role of an interventional radiologist? Aside from open surgery, what other treatments are available in Malaysia that you might consider? 播放影片 播放影片 06:02 The Truth About Electric Field Cancer Therapy in Japan Understanding Cancer Therapy in Japan with Dr. Shin Akiyama, specialist in Tokyo, Japan. 播放影片 播放影片 06:07 NET News 2016 Dr. Warsito P. Taruno has made significant contributions to the field of science and technology, particularly in the area of medical device development. 播放影片 播放影片 01:46 Dr. Warsito receiving BJ Habibie Technology Award in 2015 The Habibie Prize is an international award established in 2003 to honor individuals or organizations who have made significant contributions to the promotion of democracy and human rights in Indonesia and Southeast Asia. The prize is named after the late Dr. Ing. Bacharuddin Jusuf Habibie, the former president of Indonesia, who was a strong advocate for democracy, human rights, and technological development. The award ceremony is usually held in Jakarta, Indonesia, and is attended by prominent figures in the fields of politics, academia, and civil society. The Habibie Prize is administered by the Habibie Center, a think tank established by Dr. Habibie in 1999 to promote democratic governance, human rights, and sustainable development in Indonesia and Southeast Asia. The selection of the prize recipient is made by an independent jury, consisting of individuals with expertise in the fields of democracy and human rights. Some of the previous recipients of the Habibie Prize include former Philippine President Corazon Aquino, Burmese pro-democracy leader Aung San Suu Kyi, and Indonesian human rights activist Munir Said Thalib. 播放影片 播放影片 06:54 Dr. Warsito, inventor of ECCT was featured in an interview with Sarah Sechan, a popular Indonesian TV host During the interview, Dr. Warsito discussed his work on developing ECCT and explained how ECCT work by detecting the electromagnetic waves emitted by cancer cells, allowing for earlier detection and more targeted treatment. Dr. Warsito also talked about his hopes for the future of cancer treatment and the potential impact of his technology on the lives of cancer patients around the world.